News

Latest

Hospital representatives are invited to learn more about recent policy activity impacting the Medicare Recovery Audit Contractor program and review results from the AHA's latest RACTrac su
The District of Columbia federal court cannot properly resolve hospitals’ legal challenge to a 0.2% rate cut by the Centers for Medicare & Medicaid Services by giving the agency another o
There is little or no competition in Medicare Advantage markets in 97% of U.S.
Hospitals are working with a wide variety of community partners to promote population health, according to a recent survey conducted by the AHA’s Health Research & Educational Trust and A
The prevalence of narrow physician networks in the Health Insurance Marketplaces varied widely by state in 2014, according to a new
The Department of Health and Human Services’ Assistant Secretary for Preparedness and Response has released a
AHA’s Hospitals in Pursuit of Excellence initiative will host a free Sept.
The Centers for Medicare & Medicaid Services has updated its list of ICD-10 diagnosis c
A recent study of just one year and 12 markets fo
The AHA’s Physician Leadership Forum and the Association of American Medical Colleges will host a webinar Sept.
The largest insurers in the Health Insurance Marketplace raised premiums an average 75% more this year than smaller insurers in the same state, according to a new
The Centers for Medicare & Medicaid Services has
The Centers for Medicare & Medicaid Services has released software for calculating Medicare payments for inpatient care in fiscal year 2016 using ICD-10 codes.
Missouri-area hospitals had an average turnover rate of 16.3% among health care professionals in 2014, up from 12.9% in 2013, according to a new
The AHA and its Health Research & Educational Trust affiliate are surveying hospitals about their efforts to improve hospital discharge transitions as part a
Real change is happening in the city of Whittier, Calif., thanks to a health and wellness initiative that’s both for and powered by the community.
The Food and Drug Administration has issued “warning letters” to three duodenoscope manufacturers alleging certain regulatory violations. Olympus Corp. of the Americas and Hoya Corp.